Helicobacter pylori infects more than 40% of the world's population, with prevalence highest in low- and middle-income regions, and is the leading cause of infection-attributable cancer at around 850,000 gastric cancers a year.
Esomeprazole, pantoprazole and rabeprazole all come standalone, in oral combination and as a lyophilised injection.
Range depth
22 esomeprazole, 20 pantoprazole and 14 rabeprazole presentations.
Ursodeoxycholic acid in four strengths.
Tell us the market and what you already stock.
Start the conversation